In addition, phosphoproteomic analysis was performed on 96 tumor samples and 90 NAT samples using a Fe-NTA phosphopeptides enrichment strategy (Fig. 1a and Supplementary Fig. S1a). Here, BRD2 is linked to neoplasm.